Ubrogepant

pharmacological · nervous · digestive · Oral

Ubrogepant. Small-molecule CGRP receptor antagonist for acute migraine. Same trigeminovascular CLR/RAMP1 receptor target as rimegepant; shorter half-life. CYP3A4…

Small-molecule CGRP receptor antagonist for acute migraine. Same trigeminovascular CLR/RAMP1 receptor target as rimegepant; shorter half-life. CYP3A4 substrate — strong inhibitors contraindicated.

Sources: PMID:38266060, PMID:42212509